Great ideas are the starting point, not the endpoint. We define ourselves through the act of putting inspiration into practice, finding viable solutions for challenges. Our mission is to translate scientific insight into clinical practice, developing innovative products for patients with high medical need.

Historically, the pharmaceutical industry carried discoveries from basic research into clinical trials; recent developments have effected a dramatic change in this process. The basic and clinical research sectors have as a result diverged and the emerging gap is considered “the valley of death” in translational research. TRON is most active at this interface, specializing in the areas of target discovery, validation, and preclinical development.  Our extensive collaborations and expertise allow us to strongly support work in phase I and II clinical trials